@article{0796f77b9ddf468d9d5ea486e11bada0,
title = "Decreased nasal polyp eosinophils but increased mast cells in a patient with aspirin-exacerbated respiratory disease treated with reslizumab",
author = "Staudacher, {Anna G.} and Peters, {Anju T.} and Carter, {Roderick G.} and Welch, {Kevin C.} and Stevens, {Whitney W.}",
note = "Funding Information: Funding Sources: This research was supported in part by grants from the National Institutes of Health (KL2 TR001424, K23 AI141694, R01 AI137174, U19 AI106683, and P01 145818), the Parker B. Francis Fellowship Foundation, the Hope American Partnership for Eosinophilic Disorders/American Academy of Allergy, Asthma, and Immunology Pilot Grant Award, and the Ernest S. Bazley Foundation.The authors thank the following members of the Northwestern Sinus Center for their assistance with this manuscript: Robert P. Schleimer, PhD; Atsushi Kato, PhD; Lydia Suh, BS; Caroline P.E. Price, BA; James E. Norton, MS; Julia H. Huang, MS; Kathryn E. Hulse, PhD; Leslie C. Grammer, MD; David B. Conley, MD; Stephanie Shintani-Smith, MD; Bruce K. Tan, MD, MS; and Robert C. Kern, MD. The authors would also like to acknowledge the Northwestern University RHLCCC Pathology Core Facility and Cancer Center Support Grant (NCI CA060553) with help from Bernice Frederick providing histology services for tissue processing and sectioning for further analysis.",
year = "2020",
month = oct,
doi = "10.1016/j.anai.2020.06.043",
language = "English (US)",
volume = "125",
pages = "490--493.e2",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "4",
}